We have evaluated the FLIPR Calcium 3 Assay Kit (Calcium 3), a new no-wash fluorescence calcium indicator dye reagent, for the measurement of agonist-stimulated calcium signaling in cells expressing the serotonin 2C (5-HT 2C ), metabotropic glutamate receptor 5 (mGluR5) and the vasopressin 2 (V2) G-protein-coupled receptors. Calcium 3 yielded equivalent (5-HT 2C ) or superior (mGluR5 and V2) sensitivity to FLUO-4 as indexed by the change in fluorescence counts following agonist application. Assay variability, indexed by CV, using Calcium 3 or FLUO-4 was equivalent with 5-HT 2C receptor responses although CVs were reduced using Calcium 3 in the examples of the mGluR5 and V2 receptors. Receptor pharmacologies based on agonist EC 50 values were identical when either Calcium 3 or FLUO-4 were utilized. Our results validate Calcium 3 as a compelling alternative to FLUO-4 in the choice of fluorescent dye reagent for studying G-protein-coupled receptors, providing the advantage of a homogenous, no-wash assay format. (Journal of Biomolecular Screening 2003:571-577) 
INTRODUCTION

F
LUORESCENT DYE INDICATORS for Intracellular calcium measurements are widely used tools in biology, in particular in the field of G-protein-coupled receptor (GPCR) pharmacology and functional characterization. Exemplified by FURA-2, 1 one of the 1st calcium indicator dyes to receive widespread use, these dyes report increases in intracellular calcium by virtue of changes in their fluorescence signal upon calcium binding. In the FURA-2 example, the spectral shift following calcium binding allows for ratiometric measurement of calcium concentration with dual wavelength UV excitation and single wavelength emission. Newer generation calcium indicators such as FLUO-3 2 and FLUO-4 3 offer greater sensitivity with larger changes in fluorescence intensity following calcium binding, are excited with visible light sources, and lack a significant spectral shift following calcium binding; thus, their use is typically restricted to assessment of qualitative changes in calcium. In addition to these reagents, 2 no-wash calcium assay kits have been introduced in support of the fluorometric imaging plate reader (FLIPR) platform, the FLIPR Calcium Assay Kit and the Calcium Plus Assay Kit. These reagents utilize quenching technology 4 to eliminate background fluorescence thereby providing a homogenous no-wash assay format as an alternative to the more time-consuming FLUO-3 and FLUO-4 wash protocols. Despite the significant advantage of a homogenous assay, these reagents have not eliminated the use of FLUO-3 and FLUO-4, which are often more sensitive and yield better responses across a more diverse spectrum of biological targets.
Although the current FLIPR dyes may have some limitations, the utility of the FLIPR in performing functional characterization of receptors is well validated as evidenced by an increasing number of publications. In particular, the characterization of GPCRs signaling through the Gq-phospholipase C cascade, leading to increases in intracellular calcium, has been facilitated by the introduction of this high-throughput technology. To date, a number of Gq-coupled receptors have been profiled in some detail with respect to both agonist and antagonist pharmacology including the 5-HT2 receptor subfamily, 5, 6 the orexin receptors, 7-9 the histamine H1 subtype, 10 bradykinin B1 and B2 receptors, 11 the bombesin BB2 receptor, 12 and the P2Y purinergic receptors. 13 In addition, the VR1 vanilloid receptor, a receptor-gated cation channel highly permeable to calcium ions, has also been extensively studied using this approach. 14, 15 In addition to the Gq-coupled receptors, it has been possible to study Gs-and Gi-coupled receptors using the FLIPR assay platform by taking advantage of the promiscuous Gprotein, G15/16, or using chimeric G-proteins comprising Gq with the C-terminal 5 amino acids replaced with those from Gs or 1 of the Gi family members. 16 By taking advantage of this approach, the Gs-coupled 5-HT 6 17 and 5-HT 7 receptors,  18 and the Gi-coupled  GABA-B,  19 H3,  20 and mGluR 2 and 4 
MATERIALS AND METHODS
Cell lines
A stable Chinese hamster ovary cell line expressing the 5-HT 2C receptor subtype (VNI isoform) and a stable human embryonic kidney (HEK) cell line expressing the mGluR5 receptor were utilized. Both the 5-HT 2C and mGluR5 receptors couple primarily via Gq to the activation of phospholipase C with subsequent elevation of intracellular calcium. Calcium signaling with the normally Gscoupled V2 receptor was observed following transient expression of the receptor in HEK cells. For transient expression, HEK cells seeded at a density of 3 × 10 6 in 10 cm 2 dishes were transfected using the Lipofectamine reagent (Invitrogen, Carlsbad, CA) with 2 µg/DNA/plate V2 receptor (pcDNA3.1 vector). Twenty-four hours following transfection, cells were seeded into poly-D-lysinecoated, 96-well, black-wall, clear-bottom plates (Becton Dickinson, Franklin Lakes, NJ) at a density of 60-80,000 cells/ well and were used next day for FLIPR assays. Similarly, the stable HEK/mGluR5 cells were seeded at 80,000 cells/well into poly-Dlysine-coated, 96-well, black-wall, clear-bottom plates, whereas the stable CHO/5-HT 2C cells were seeded at 40,000 cells/well into noncoated plates.
FLUO-4 FLIPR studies
5-HT 2C , mGluR5, and V2 receptor coupling to increases in intracellular-free calcium was measured using the fluorometric imaging plate reader (FLIPR, Molecular Devices, Sunnyvale, CA). Growth medium was removed by aspiration, and cells were washed twice with 200 µl Hank's buffered saline solution (Mediatech, Herndon, VA) supplemented with 20 mM HEPES and 2.5 mM probenecid (HBS). Dye loading buffer comprised FLUO-4-AM (Molecular Probes, Eugene, OR) at 2 µM final concentration, 1% fetal bovine serum (US Biotechnologies, Parker Ford, PA), and 0.1% pluronic acid (Molecular Probes, Eugene, OR). After washing, cells were loaded with the calcium indicator dye FLUO-4-AM reagent for 60 min at 37°C. Subsequently, cells were washed twice with HBS at room temperature, 180 µl HBS was added to each well, and plates were transferred to FLIPR for acquisition of calcium images. In the case of the mGluR5-expressing cells, all assay buffers were supplemented with glutamicpyruvate transaminase (GPT) and pyruvic acid to prevent accumulation of glutamate, thereby precluding desensitization of the receptor. Excitation at 488 nm was achieved with an argon ion laser, and a 515 nm emission filter was used. In each experiment, baseline fluorescence after dye loading was adjusted to 10,000 fluorescence counts by adjusting the strength of the laser. Fluorescence images and relative intensities were captured at 1-s intervals, and cells were stimulated by addition of agonist (20 µl) after 10 baseline measurements. Unless indicated otherwise, reagents were from Sigma-Aldrich (St. Louis, MO).
Calcium 3 FLIPR studies
Growth medium was removed by aspiration, 180 µl Calcium 3 reagent (Molecular Devices, Sunnyvale, CA), reconstituted in HBS, was added, and cells were loaded for 60 min at 37°C. Subsequently, plates were transferred to FLIPR for acquisition of calcium images. As described above, assay buffers used with the mGluR5-expressing cells additionally contained GPT and pyruvic acid.
Data analysis
An increase in fluorescence counts corresponds to an increase in intracellular calcium. The temporal profile for calcium responses was averaged across replicates, and raw fluorescence counts were used for graphical representation. For the evaluation of agonist pharmacology, the calcium changes in response to different concentrations of agonist were determined using a maximum minus minimum calculation of the raw fluorescence count data. Calcium changes were then expressed as a percentage of the response observed with a maximally effective concentration of 5-HT, L-glutamate, or vasopressin, and EC 50 values were estimated by nonlinear regression curve fitting using the log-concentration percent maximum response curves. Statistical comparison between Calcium 3 and FLUO4 maximal and half-maximal responses was performed using Student's unpaired t test.
RESULTS
5-HT 2C receptor responses
5-HT 2C receptor-coupled calcium transients in response to maximally effective (10 µM) and approximate half-maximal EC 50 (0.3 nM) concentrations of 5-HT are presented in Figure 1A for Calcium 3-loaded cells and Figure 1B for FLUO-4-loaded cells. Dye sensitivities were equivalent based on the maximal fluorescence response achieved with either Calcium 3 (22974 ± 1991) or FLUO-4 (22760 ± 2078), and CVs (8%-9%) were comparable. In the presence of 0.3 nM 5-HT, a higher fluorescence change, achieving statistical significance (p < 0.001, n = 96), was observed with Calcium 3 (13773 ± 2280) compared with FLUO-4 (10809 ± 1283), although this was associated with a slightly higher CV for the former (16% compared with 12% for FLUO-4). 5-HT 2C receptor agonist pharmacology was also compared with the 2 dye reagents. The rank order of estimated agonist EC 50 values (5-HT > WAY-161503 > DOI > Ro 60-0175) was identical when either Calcium 3 ( Fig. 2A) or FLUO-4 (Fig. 2B ) was utilized. Table 1 presents the estimated EC 50 values for the stimulation of calcium signaling by the compounds evaluated, indicating a trend toward increased potency when evaluated with Calcium 3 compared with FLUO-4.
With respect to the 5-HT 2C receptor, we have previously validated and utilized a FLUO-3-based FLIPR assay identical in procedure to the one described here for FLUO-4. Therefore, in this case, we also performed a side-by-side comparison of the FLUO-3 responses with those obtained with Calcium 3. The maximal and approximate EC 50 calcium responses to 5-HT for measurements with Calcium 3 (Fig. 3A) and FLUO-3 (Fig. 3B) are illustrated, demonstrating a greater sensitivity with Calcium 3 over FLUO-3. Maximum fluorescence responses were 23913 ± 3013 and 19014 ± 1849 for Calcium 3 and FLUO-3, respectively, whereas the responses to 0.3 nM 5-HT were 17570 ± 3129 and 12228 ± 1646. CVs for FLUO-3 (10%-14%) were slightly better than Calcium 3 (12%-18%), yet both were below an arbitrary cutoff of 20% often employed for assessing assay reproducibility. Figure 4 , the use of Calcium 3 resulted in greater sensitivity and reduced variability when compared with FLUO-4 in this comparison. Maximal and approximate half-maximal responses to L-glutamate measured with Calcium 3 were 13694 ± 1698 and 6860 ± 1827, respectively, and CVs were in the 12%-27% range. In contrast, maximal and approximate half-maximal responses to L-glutamate measured with FLUO-4 were 10960 ± 2592 and 6105 ± 1839, respectively, with CVs in the range 24%-30%. Statistically significant differences in favor of Calcium 3 were determined for both the maximal (p < 0.001, n = 96) and half-maximal (p < 0.01, n = 96) dye responses to L-glutamate. Agonist rank order of potency was equivalent (Lquisqualate > L-glutamate > (S)-DHPG = L-CCG-I) with both reagents (Fig. 5) , as were the estimated EC 50 values, which are presented in Table 2 for the compounds studied. 
V2 receptor responses
Transient expression of the normally Gs-coupled V2 receptor in HEK cells resulted in robust calcium responses following application of [Arg 8 ]-vasopressin (AVP). Calcium responses following addition of 1 µM (maximal) and 1 nM (approximate halfmaximal) AVP are shown in Figure 6A for Calcium 3 and Figure  6B for FLUO-4. Greater sensitivity was observed with Calcium 3 at both 1 nM (20670 ± 934) and 1 µM (37008 ± 988) compared with FLUO-4 (16950 ± 3332 and 29275 ± 3766 at 1 nM and 1 µM, respectively), and CVs were improved with Calcium 3 (3%-5%) over FLUO-4 (13%-20%). The potency of AVP (Fig. 7) was equivalent with either Calcium 3 (0.6 nM) or FLUO-4 (0.7 nM). Data represent EC 50 values (µM) determined from the log-concentration response curves presented in Figures 5A and 5B. 
DISCUSSION
The FLIPR platform for high-throughput calcium signaling assays is now well established as an efficient system for the characterization of GPCRs coupled through Gq to the mobilization of intracellular calcium, with the additional potential for evaluation of non-Gq-coupled GPCRs using chimeric and/or promiscuous Gproteins. To this end, investigators have a number of options with respect to fluorescent indicator dyes for this application including FURA-2, FLUO-3, FLUO-4, and the no-wash reagents, FLIPR Calcium and Calcium Plus assay kits. In this study, we have evaluated a new no-wash dye reagent, FLIPR Calcium 3 Assay Kit (Calcium 3), in comparison with FLUO-4, the current gold standard with respect to sensitivity. Because one of the current limitations of the existing no-wash dyes is applicability of use across a number of receptor systems, we examined 3 divergent GPCRs. The 5-HT 2C and V2 receptors are members of the family A rhodopsin-like receptors and are activated by a small molecule neurotransmitter (5-HT) and hormone/neuropeptide (AVP), respectively, whereas the mGluR5 belongs to the family C receptors and is activated by Lglutamate. The choice of these receptor targets was, in part, based on our previous experiences with the FLIPR Calcium and Calcium Plus assay kits where we have found these to work well with the 5-HT2C receptor cell line, yet rather poorly with both the mGluR5-and V2-expressing systems (unpublished observations).
With essentially no requirement for assay optimization, other than following the suggested assay protocol, it was quickly established that Calcium 3 yielded robust calcium responses with all of the 3 receptor systems examined. Moreover, dye sensitivity of Calcium 3 was at least equivalent to that of FLUO-4 as was the case with the CHO/5-HT 2C example, and was improved over FLUO-4 with both the HEK/mGluR5 stable line and HEK/V2 transient transfectants. One can speculate that these differences in apparent sensitivity may be related to the different plate attachment properties of CHO versus HEK cells. Generally, CHO cell lines work well in cell-based assays by virtue of their good attachment properties. In the case of HEK lines, it is typically necessary to re-plate cells onto poly-D-lysine-coated plates to improve their attachment properties. Although the present studies were conducted under these conditions, it is possible that modest cell loss during the FLUO-4 wash protocol might contribute to the reduced fluorescence counts following agonist application. Clearly, one advantage of a no-wash protocol is its application to cells that do not have favorable attachment properties.
In addition to favorable sensitivity, the use of Calcium 3 did not appear to compromise on the reproducibility of the assays evaluated in this study. In fact, CVs were either equivalent or reduced with Calcium 3, indicating that in certain assay systems, its use resulted in a reduction in variability. Although the assays studied here were robust and well validated, reproducibility is certainly a consideration, in particular in the development of new assays and those where smaller signals may be encountered. Besides an evaluation of sensitivity and variability, it was also important to compare receptor pharmacologies established using Calcium 3 compared with FLUO-4. This is clearly an important consideration for investigators who have already validated calcium assays using other fluorescent indicators. For each of the 3 receptors examined here, agonist EC 50 values were identical using either Calcium 3 or FLUO-4, and this validation of the Calcium 3 assay was achieved efficiently and rapidly. Given the ease of transition, we expect that other assays will be readily amenable to transfer to the Calcium 3 reagent.
In summary, Calcium 3, a new no-wash fluorescence calcium indicator dye reagent, is a sensitive and reproducible indicator for intracellular calcium. Dye performance is at least equivalent or superior to FLUO-4, with the added advantage of a homogenous nowash protocol. 
